Beyond taxanes: the next generation of microtubule-targeting agents
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Beyond taxanes: the next generation of microtubule-targeting agents
Authors
Keywords
-
Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume 133, Issue 3, Pages 821-830
Publisher
Springer Nature
Online
2011-11-23
DOI
10.1007/s10549-011-1875-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Progress on Kinesin Spindle Protein Inhibitors as Anti-Cancer Agents
- (2013) Yingjie Zhang et al. Anti-Cancer Agents in Medicinal Chemistry
- RIBBON-1: Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Chemotherapy With or Without Bevacizumab for First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative, Locally Recurrent or Metastatic Breast Cancer
- (2011) Nicholas J. Robert et al. JOURNAL OF CLINICAL ONCOLOGY
- Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study
- (2011) Javier Cortes et al. LANCET
- Phase I trial of ixabepilone plus pegylated liposomal doxorubicin in patients with adenocarcinoma of breast or ovary
- (2010) E. Chuang et al. ANNALS OF ONCOLOGY
- Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2010) F. Cardoso et al. ANNALS OF ONCOLOGY
- Analysis of overall survival from a phase III study of ixabepilone plus capecitabine versus capecitabine in patients with MBC resistant to anthracyclines and taxanes
- (2010) Gabriel N. Hortobagyi et al. BREAST CANCER RESEARCH AND TREATMENT
- Phase II study evaluating the efficacy and safety of sagopilone (ZK-EPO) in patients with metastatic breast cancer that has progressed following chemotherapy
- (2010) Phuong K. Morrow et al. BREAST CANCER RESEARCH AND TREATMENT
- Efficacy of ixabepilone in ER/PR/HER2-negative (triple-negative) breast cancer
- (2010) Edith A. Perez et al. BREAST CANCER RESEARCH AND TREATMENT
- Ixabepilone plus capecitabine in metastatic breast cancer patients with reduced performance status previously treated with anthracyclines and taxanes: a pooled analysis by performance status of efficacy and safety data from 2 phase III studies
- (2010) Henri Roché et al. BREAST CANCER RESEARCH AND TREATMENT
- A Phase II Trial of Vinflunine As Monotherapy or in Combination with Trastuzumab as First-Line Treatment of Metastatic Breast Cancer
- (2010) Denise A. Yardley et al. CANCER INVESTIGATION
- Visceral Disease in Patients With Metastatic Breast Cancer: Efficacy and Safety of Treatment With Ixabepilone and Other Chemotherapeutic Agents
- (2010) Denise A. Yardley Clinical Breast Cancer
- Phase III Trials of Eribulin Mesylate (E7389) in Extensively Pretreated Patients With Locally Recurrent or Metastatic Breast Cancer
- (2010) Chris Twelves et al. Clinical Breast Cancer
- Activity of the Kinesin Spindle Protein Inhibitor Ispinesib (SB-715992) in Models of Breast Cancer
- (2010) J. W. Purcell et al. CLINICAL CANCER RESEARCH
- Eribulin mesylate for the treatment of breast cancer
- (2010) Tessa Cigler et al. EXPERT OPINION ON PHARMACOTHERAPY
- A phase I study of ispinesib, a kinesin spindle protein inhibitor, administered weekly for three consecutive weeks of a 28-day cycle in patients with solid tumors
- (2010) Howard A. Burris et al. INVESTIGATIONAL NEW DRUGS
- Phase II Study of the Halichondrin B Analog Eribulin Mesylate in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With an Anthracycline, a Taxane, and Capecitabine
- (2010) Javier Cortes et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase III Trial of Ixabepilone Plus Capecitabine Versus Capecitabine in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane
- (2010) Joseph A. Sparano et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Study of Bevacizumab Plus Docetaxel Compared With Placebo Plus Docetaxel for the First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer
- (2010) David W. Miles et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase 2 Study of Single-Agent IV Vinflunine as Third-Line Treatment of Metastatic Breast Cancer After Failure of Anthracycline-/Taxane-Based Chemotherapy
- (2009) Pierre Fumoleau et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- A phase II trial of trastuzumab plus weekly ixabepilone and carboplatin in patients with HER2-positive metastatic breast cancer: an Eastern Cooperative Oncology Group Trial
- (2009) Stacy Moulder et al. BREAST CANCER RESEARCH AND TREATMENT
- First-Line Chemotherapy for Metastatic Breast Cancer
- (2009) Melinda L. Telli et al. Clinical Breast Cancer
- Phase II Study of Eribulin Mesylate, a Halichondrin B Analog, in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane
- (2009) Linda T. Vahdat et al. JOURNAL OF CLINICAL ONCOLOGY
- Detecting an Overall Survival Benefit that Is Derived From Progression-Free Survival
- (2009) Kristine R. Broglio et al. JNCI-Journal of the National Cancer Institute
- Treatment Options for Breast Cancer Resistant to Anthracycline and Taxane
- (2009) Alvaro Moreno-Aspitia et al. MAYO CLINIC PROCEEDINGS
- A phase I trial of ispinesib, a kinesin spindle protein inhibitor, with docetaxel in patients with advanced solid tumours
- (2008) S P Blagden et al. BRITISH JOURNAL OF CANCER
- Preclinical efficacy spectrum and pharmacokinetics of ixabepilone
- (2008) Francis Y. F. Lee et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Indibulin, a Novel Microtubule Inhibitor, Discriminates between Mature Neuronal and Nonneuronal Tubulin
- (2008) A. Wienecke et al. CANCER RESEARCH
- Activity of Ixabepilone in Patients with Metastatic Breast Cancer with Primary Resistance to Taxanes
- (2008) Denise A. Yardley Clinical Breast Cancer
- Synergistic Antitumor Activity of Ixabepilone (BMS-247550) Plus Bevacizumab in Multiple In vivo Tumor Models
- (2008) F. Y.F. Lee et al. CLINICAL CANCER RESEARCH
- Vinflunine: A New Microtubule Inhibitor Agent
- (2008) J. Bennouna et al. CLINICAL CANCER RESEARCH
- Ixabepilone: A Novel Antineoplastic Agent with Low Susceptibility to Multiple Tumor Resistance Mechanisms
- (2008) L. Vahdat ONCOLOGIST
- Clinical Development of Ixabepilone and Other Epothilones in Patients with Advanced Solid Tumors
- (2008) E. Rivera et al. ONCOLOGIST
- Cellular Mechanisms of Resistance to Anthracyclines and Taxanes in Cancer: Intrinsic and Acquired
- (2008) A. Jo Chien et al. SEMINARS IN ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now